Global Multiplexed Diagnostics Market to be worth US$9.8 bn by 2019
Multiplexed diagnostics offer faster results in limited samples, thereby saving both time and money. The technique is extensively used to detect and analyze various assays and offers advantages such as testing of a host of markers at the same time and reading a large volume of data at once. Multiplexed diagnostics assure accurate test results through the addition of calibration curves, internal quality controls, and quality standards.
Download Free Sample Report Brochure PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1719
The report points out that the growing prevalence of cancer and various infectious diseases has boosted the demand for multiplexed diagnostics. Extensive usage of multiplexed diagnostics across life sciences research and clinical diagnostics, along with the evolving regulatory landscape, has further augmented the growth of the global multiplexed diagnostics market. However, lack of skilled labor and costly equipment are expected to restrain the overall market. The global multiplexed diagnostics market has a huge opportunity to grow with the development of generic platforms and the introduction of automated multiplexed diagnostic instruments.
On the basis of technology, the report categorizes the global multiplexed diagnostics market into high density multiplexed assays, very high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays, and next generation sequencing assays. Currently, the medium density multiplexed assays segment is leading the overall market, followed by the low density multiplexed assays segment. Bead-based arrays and antibody arrays are the most utilized multiplexed diagnostic techniques.
In terms of applications, the report segments the global multiplexed diagnostics market into infectious disease diagnosis, oncology, autoimmune diseases, allergies, cardiac diseases, and others. The demand for multiplexed diagnostics for oncology, cardiac, and infectious diseases is expected to surge in the coming years.
The report studies the multiplexed diagnostics market across four key regions: Europe, North America, Asia Pacific, and Rest of the World. North America dominates the overall market owing to the advanced healthcare and medical infrastructure in the region. During the forecast horizon, Asia Pacific is projected to witness rapid growth, with the growing prevalence of cardiac ailments and infectious diseases. Demand from Japan is anticipated to drive the market in the region, followed by China and India.
Describing the competitive landscape, the report profiles some of the key players in the global multiplexed diagnostics market such as Agilent Technologies Inc., Affymetrix Inc., BioMerieux Inc., Illumina Inc., Bio-Rad Laboratories, Gen-Probe Inc., F. Hoffman-La Roche Ltd., Luminex Corporation, Life Technologies Corporation, and Seegene Inc. The report provides detailed information about the key players including their product portfolio, financial overview, business strategies, and recent developments.
Browse Full Report@ http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html